Minimal Residual Disease (MRD) ratio before and after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

被引：0
|
作者：
Boncompagni, Riccardo [1 ]
Staderini, Michela [2 ]
Nozzoli, Chiara [1 ]
Antonioli, Elisabetta [2 ]
Caporale, Roberto [3 ]
Peruzzi, Benedetta [3 ]
Cutini, Ilaria [1 ]
Gozzini, Antonella [1 ]
Serena, Mariotti [1 ]
Guidi, Stefano [1 ]
Jance, Blerina [3 ]
Accogli, Barbara [2 ]
Francesco, Annunziato [3 ]
Bosi, Alberto [2 ]
Saccardi, Riccardo [1 ]
机构：
[1] AOU Careggi, Cell Therapy & Transfus Med Unit, Florence, Italy
[2] AOU Careggi, Hematol Unit, Florence, Italy
[3] AOU Careggi, Diagnost Ctr Cytometry & Immunotherapy, Florence, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
autologous stem cell transplant; Minimal residual disease; Progression-free survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP-203
引用
收藏
页码：E172 / E172
页数：1
相关论文
共 50 条
  • [1] Minimal residual disease (MRD) ratio before and after autologous stem cells transplantation (ASCT) in multiple myeloma (MM)
    Boncompagni, Riccardo
    Staderini, Michela
    Nozzoli, Chiara
    Antonioli, Elisabetta
    Accogli, Barbara
    Saccardi, Riccardo
    BONE MARROW TRANSPLANTATION, 2019, 54 : 121 - 122
  • [2] MONITORING OF MINIMAL RESIDUAL DISEASE (MRD) IN PATIENTS WITH MULTIPLE MYELOMA (MM) BEFORE AND AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)
    Galtseva, I.
    Mendeleeva, L.
    Pokrovskaya, O.
    Kastrikina, I.
    Urnova, E.
    Kuzmina, L.
    Parovichnikova, E.
    Savchenko, V.
    HAEMATOLOGICA, 2014, 99 : 647 - 647
  • [3] MINIMAL RESIDUAL DISEASE (MRD) RATIO BEFORE AND AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION (ASCT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)
    Antonioli, E.
    Nozzoli, C.
    Staderini, M.
    Boncompagni, R.
    Caporale, R.
    Peruzzi, B.
    Bosi, A.
    Saccardi, R.
    HAEMATOLOGICA, 2019, 104 : 66 - 66
  • [4] Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)
    Foureau, David
    Zhang, Qing
    Cogdill, Tammy D.
    Wynn, Adina S.
    Steuerwald, Nury M.
    Druhan, Lawrence J.
    Guo, Fei
    Rigby, Katherine
    Madden, Kyle L.
    Symanowski, James T.
    Avalos, Belinda R.
    Copelan, Edward A.
    Usmani, Saad Z.
    Bhutani, Manisha
    BLOOD, 2016, 128 (22)
  • [5] Autologous stem cell transplantation (ASCT) is still crucial for multiple myeloma (MM) patients with undetectable minimal residual disease after induction treatment
    Yan, Wenqiang
    Liu, Jiahui
    Fan, Huishou
    Xu, Jingyu
    Cui, Jian
    Qiu, Lugui
    Zou, Dehui
    An, Gang
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S117 - S118
  • [6] Prospective evaluation of minimal residual disease in multiple myeloma following autologous stem cell transplantation(ASCT) and consolidation therapy.
    Patekar, Mukesh
    Kumar, Lalit
    Sharma, Atul
    Gupta, Ritu
    Vishnubhatla, Sreenivas
    Naik, Ramavath Devendra
    Pai, Rohit Ramesh
    Tiwari, Akash
    Dahiya, Meetu
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Monitoring of minimal residual disease among multiple myeloma patients after autologous stem cell transplantation
    Akhundova, F.
    Mendeleeva, L.
    Galtseva, I.
    Pokrovskaya, O.
    Urnova, E.
    Parovichnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S258 - S259
  • [8] Multiple myeloma: Maintenance therapy after autologous stem cell transplantation, depending on minimal residual disease
    Solovyev, M. V.
    Mendeleeva, L. P.
    Pokrovskaya, O. S.
    Nareyko, M. V.
    Firsova, M. V.
    Galtseva, I. V.
    Davydova, Yu. O.
    Kapranov, N. M.
    Kuzmina, L. A.
    Gemdzhian, E. G.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 25 - 31
  • [9] Deferring autologous stem cell transplantation for consolidation of minimal residual disease in multiple myeloma
    Braunstein, Marc
    Niesvizky, Ruben
    SEMINARS IN ONCOLOGY, 2016, 43 (06) : 709 - 711
  • [10] Minimal residual disease evaluation in autologous stem cell transplantation recipients with multiple myeloma
    Gupta, Ritu
    Kumar, Lalit
    Dahiya, Meetu
    Mathur, Nitin
    Harish, P.
    Sharma, Atul
    Sharma, Om Dutt
    Shekhar, Varun
    LEUKEMIA & LYMPHOMA, 2017, 58 (05) : 1234 - 1237
12345